NCT00252577View on ClinicalTrials.gov

Genetic Predictors of Lithium Response in Bipolar Disorder

CompletedOBSERVATIONAL

Enrollment

130

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions

Bipolar Disorder

Interventions

DRUG

Lithium treatment

Lithium is a standard treatment for bipolar disorder. Patients will be stabilized on lithium monotherapy over a 3 month period, observed for one month, and then followed every 2 months in maintenance phase for 2 years

Trial Locations (1)

92161

VA San Diego Healthcare System, San Diego, CA, San Diego

All Listed Sponsors

lead

VA Office of Research and Development

FED

NCT00252577 - Genetic Predictors of Lithium Response in Bipolar Disorder | Biotech Hunter | Biotech Hunter